Results 181 to 190 of about 182,666 (399)

Norman Julius Zabusky OBITUARY [PDF]

, 2018
Norman Julius Zabusky, who laid the foundations for several critical advancements in nonlinear science and experimental mathematics, died of idiopathic pulmonary fibrosis on 5 February 2018 in Beersheba, Israel.
Campbell, David K., Newell, Alan C., Porter, Mason A.   +2 more
core   +1 more source

Epithelial–Mesenchymal Transition in the Pathogenesis of Idiopathic Pulmonary Fibrosis

Medicina, 2019
Idiopathic pulmonary fibrosis (IPF) is a serious disease of the lung, which leads to extensive parenchymal scarring and death from respiratory failure. The most accepted hypothesis for IPF pathogenesis relies on the inability of the alveolar epithelium ...
F. Salton, M. C. Volpe, M. Confalonieri
semanticscholar   +1 more source

Exploring the Causal Relationship Between Immune Cells and Idiopathic Pulmonary Fibrosis: A Mendelian Randomization Analysis

Journal of Clinical Laboratory Analysis, EarlyView.
Immunophenotypes of immune cells associated with idiopathic pulmonary fibrosis analyzed by the IVW method. ABSTRACT Background Idiopathic pulmonary fibrosis (IPF) is a progressive and irreversible interstitial lung disease with a complex pathogenesis involving multiple immune cells.
Peng Gong, Yimin Lu, Xi Chai, Xiaobo Li
wiley   +1 more source

Bronchoalveolar Lavage Lipids in Idiopathic Pulmonary Fibrosis [PDF]

, 1989
Robert B. Low
openalex   +1 more source

Diagnostic test interpretation and referral delay in patients with interstitial lung disease. [PDF]

, 2019
BACKGROUND:Diagnostic delays are common in patients with interstitial lung disease (ILD). A substantial percentage of patients experience a diagnostic delay in the primary care setting, but the factors underpinning this observation remain unclear.
Adegunsoye, Ayodeji, Boctor, Noelle, Chung, Jonathan H, DiGeronimo, Ryan, Kadoch, Michael, Lafond, Elyse, Oldham, Justin M, Pan, Isabella, Pritchard, David, Pugashetti, Janelle Vu, Sarma, Nandini, Strek, Mary   +11 more
core   +1 more source

Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials [PDF]

, 2013
Rationale Clinical trial design in interstitial lung diseases (ILDs) has been hampered by lack of consensus on appropriate outcome measures for reliably assessing treatment response.
Antoniou, K, Baughman, RP, Brown, KK, Castelino, FV, Christmann, RB, Christopher-Stine, L, Collard, HR, Cottin, V, Danoff, S, Dellaripa, PF, Denton, CP, Distler, O, Fischer, A, Flaherty, KR, Frankel, S, Highland, KB, Hummers, L, Huscher, D, Khanna, D, Kim, DS, Kowal-Bielecka, OM, LeSage, D, Lynch, DA, Matteson, EL, Merkel, PA, Miller, FW, Mittoo, S, Oddis, CV, Phillips, K, Pittrow, D, Proudman, SM, Richeldi, L, Ryu, JH, Saketkoo, LA, Sandorfi, N, Sarver, C, Seibold, JR, Shah, AA, Strand, V, Swigris, J, Wells, AU   +40 more
core   +1 more source

Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat

Respiratory Research, 2019
Idiopathic pulmonary fibrosis (IPF) is a progressive disease with a dismal prognosis. The average life expectancy of untreated patients with IPF is only 3 to 4 years. Decline in forced vital capacity (FVC) in patients with IPF appears to be almost linear,
T. Maher, M. Strek
semanticscholar   +1 more source

Ultrasound‐Based Local Lung Motion Assessment Using Synthetic Lateral Phase

Journal of Clinical Ultrasound, EarlyView.
Representative workflow images from lung motion tracking software. (A) Screen capture of user marking lung surface. (B) Screen capture of displacement heatmap and selection of region of interest for motion tracking. (C) Video of motion tracking. (D) Screen capture of breath marking.
Christopher M. Fung, Jonathan M. Rubin, Jing Gao, James D. Hamilton   +3 more
wiley   +1 more source

Cell Therapy in Idiopathic Pulmonary Fibrosis†

Medical Sciences, 2018
Idiopathic pulmonary fibrosis is a fatal disease with no effective or curative treatment options. In recent decades, cell-based therapies using stem cells or lung progenitor cells to regenerate lung tissue have experienced rapid growth in both ...
Anna Serrano-Mollar
doaj   +1 more source

Boosting Joint Models for Longitudinal and Time-to-Event Data [PDF]

arXiv, 2016
Joint Models for longitudinal and time-to-event data have gained a lot of attention in the last few years as they are a helpful technique to approach common a data structure in clinical studies where longitudinal outcomes are recorded alongside event times.
arxiv